Weishuai Zheng
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Blocking ATF4 attenuates pulmonary fibrosis by preventing lung fibroblast activation and macrophage M2 program.
Journal: International journal of biological macromolecules
Published: October 07, 2024
Associations of different combinations of moderate-vigorous physical activity and muscle-strengthening activity with mortality among US lung cancer survivors.
Journal: BMC pulmonary medicine
Published: November 28, 2023
Bhlhe40 deficiency attenuates LPS-induced acute lung injury through preventing macrophage pyroptosis.
Journal: Respiratory research
Published: September 26, 2023
Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
Journal: Clinical and experimental medicine
Published: September 09, 2023
Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population.
Journal: Inflammation
Published: June 14, 2022
Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway.
Journal: Frontiers in pharmacology
Published: December 06, 2021
Latent Transforming Growth Factor-β Binding Protein-2 Regulates Lung Fibroblast-to-Myofibroblast Differentiation in Pulmonary Fibrosis via NF-κB Signaling.
Journal: Frontiers in pharmacology
Published: October 03, 2021
Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: October 12, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026